Scholars Central

Conference abstractPublished 15 Sep 2014

Laboratory perspective on the translational aspects of cancer genomics

Authors: Chandan Kumar Sinha

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

High throughput sequencing approaches developed over the past few years enable informed precision medicine approaches for cancer, in real time. Unfortunately, from huge (and not inexpensive) sequencing data analyses, only a limited set of well characterized somatic aberrations can be effectively matched with precision therapeutic options. The large bulk of somatic aberrations identified in individual patient?s tumor samples typically include aberrations in hitherto non-actionable genes or uncharacterized aberrations in known, potentially actionable cancer genes- both scenarios being not immediately translatable. The latter set of findings represents a bottleneck in the translation of genomic findings in patient care, indicating a need for high throughput pre-clinical research in step with high throughput analyses.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Chandan Kumar Sinha”